Hypothyroid & Hashimoto's

Hypothyroidism & Hashimoto's Thyroiditis: A Nutritional and Natural-Health Reference

1. Definition and Overview

Hypothyroidism — the deficiency of thyroid hormone — is a common condition worldwide that affects almost all body systems and presents with a wide variety of clinical manifestations, ranging from being entirely asymptomatic to, in rare cases, life-threatening. It is a very common endocrine disorder that causes under-secretion of thyroid hormones, mainly thyroxine (T4) and triiodothyronine (T3). The condition affects people of every age group but is more commonly found in women and older individuals.

Hashimoto's thyroiditis is an autoimmune disease characterized by destruction of thyroid follicular cells via cell- and antibody-mediated mechanisms, and is also known as chronic autoimmune thyroiditis and chronic lymphocytic thyroiditis. It is the most common cause of hypothyroidism in developed countries. This condition was initially described by the Japanese physician Haruto Hashimoto in 1912 as "struma lymphomatosa" after he observed enlarged thyroids with lymphocytic infiltration.

Hashimoto's thyroiditis (HT) is a chronic autoimmune thyroiditis characterized by thyroid-specific autoantibodies (TPOAb and TGAb) positivity and lymphocytic infiltration, and is a major cause of hypothyroidism in iodine-sufficient regions. Epidemiological data show a significant increase in the prevalence of HT, which is about four times more common in adult women than in men. The incidence of Hashimoto thyroiditis increases with age, with most cases occurring between ages 45 and 55.

2. Pathophysiology

The pathophysiology of this disease involves the formation of antithyroid antibodies and T cell activation that target thyroid tissue, leading to progressive fibrosis. Autoantibodies directed against thyroid peroxidase (TPO) and thyroglobulin (TG), along with T-cell–driven cytotoxicity, contribute to progressive glandular inflammation, fibrosis, and loss of thyroid function.

The thyroid parenchyma is diffusely replaced by a lymphocytic infiltrate and fibrotic reaction; frequently, lymphoid germinal follicles are visible. Persons with Hashimoto's thyroiditis have serum antibodies reacting with thyroglobulin, thyroid peroxidase (TPO), and against an unidentified protein present in colloid. The pathologic features of lymphocytic infiltration, especially of T cells, and follicular destruction are the histological hallmark of autoimmune thyroiditis (AIT), leading to gradual atrophy and fibrosis.

Clinical expression is heterogeneous, ranging from euthyroidism to subclinical or overt hypothyroidism, with some individuals experiencing a transient hyperthyroid phase related to follicular cell destruction. The complex pathogenesis of HT, which results in a highly heterogeneous clinical presentation spanning several decades, makes early diagnosis and intervention very difficult.

The most common laboratory findings demonstrate elevated thyroid-stimulating hormone (TSH) and low thyroxine (T4) levels, coupled with increased anti-TPO antibodies and anti-thyroglobulin (anti-Tg) antibodies. Clinical diagnosis is mainly based on serological tests (TPOAb/TGAb) and thyroid ultrasound features.

3. Body Systems Involved

Hypothyroidism requires recognition as a common clinical issue that can affect virtually all organ systems and should always be considered in the differential diagnosis, especially when caring for older patients.

The classic symptoms of hypothyroidism include fatigue, lethargy, weight gain, and cold intolerance; however, these symptoms are non-specific and the diagnosis is typically made on biochemical grounds through serum thyroid function tests. The most common symptoms in adults are fatigue, lethargy, cold intolerance, weight gain, constipation, change in voice, and dry skin, but clinical presentation can differ with age and sex, among other factors.

The thyroxine hormone regulates the metabolism of the body, and its deficiency can cause complications in various organs of the body, potentially leading to death if not treated. Specific system-level impacts documented in the literature include:

• Metabolic system: Thyroid hormone deficiency slows metabolic rate throughout the body, affecting energy production, fat utilization, and thermogenesis in nearly every tissue.
• Cardiovascular system: Thyroid hormones play a crucial role in regulating metabolism and cardiovascular function, with even mild dysfunction — such as subclinical hypothyroidism — negatively impacting heart health.
• Musculoskeletal system: Signs such as delayed ankle jerk relaxation time and myopathy are among the documented musculoskeletal manifestations of hypothyroidism.
• Neurological system: The presentation can vary from an asymptomatic patient to myxedema coma, which is an extreme neurological presentation of severe hypothyroidism.
• Reproductive system: If hypothyroidism is left untreated, it can lead to severe complications including infertility in adults.
• Gastrointestinal system: There is growing evidence of the existence of a thyroid–gut axis that controls many autoimmune disorders, and patients frequently report changes in their quality of life and thyroid function as a result of dietary modifications.
• Skin, hair, and integument: Classic integumentary features include cold intolerance, puffiness, decreased sweating, and skin changes, though these may not always be present.

4. Contributing and Associated Factors

4.1 Genetic Factors

Genetic factors contribute approximately 70–80% and environmental factors approximately 20–30% to the pathogenesis of autoimmune thyroid disease (AITD). The process of thyroid autoimmunization develops against the background of genetic predispositions associated with class II human leukocyte antigens (HLA-DR), as well as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), protein tyrosine phosphatase non-receptor type 22 (PTPN22), and forkhead transcription box protein P3 (FOXP3).

The inheritance pattern of Hashimoto's disease is unclear because many genetic and environmental factors appear to be involved; however, the condition can cluster in families, and having a close relative with Hashimoto's disease or another autoimmune disorder likely increases a person's risk of developing the condition.

4.2 Environmental and Lifestyle Risk Factors

Environmental factors identified in the literature as influencing risk include iodine intake, vitamin D deficiency, selenium deficiency, viral infections caused by Epstein–Barr Virus (EBV), Human parvovirus B19 (PVB19), Human herpesvirus 6A (HHV-6A), and SARS-CoV-2, bacterial infection caused by Helicobacter pylori, microbiome disruption, medications such as interferon-alpha and tyrosine kinase inhibitors, as well as stress, climate, and smoking.

Beyond genetic susceptibility, environmental factors such as vitamin D deficiency, zinc, selenium, and magnesium deficiencies, as well as infections, chronic stress, pregnancy, smoking, alcohol, medications, intestinal dysbiosis, and malnutrition, also play an important role.

Regarding smoking, stopping smoking decreases the risk of Graves disease but may increase the risk of Hashimoto disease. Moderate alcohol intake is reported in some research to provide some protection against both Graves and Hashimoto disease.

4.3 Celiac Disease, Gluten, and Gut Microbiome

An association between celiac disease and autoimmune thyroid diseases including HT has been observed. The main link between the diseases is the presence of common genes in patients, such as HLA-B8, HLA-D3, HLA-DQ2, HLA-DQ8, CTLA-4, interleukin 18 (IL), and interferon gamma (IFN-γ). Hashimoto's thyroiditis has been found to occur in approximately 17% of individuals with celiac disease in some research cohorts.

The influence of many factors is emphasized, including genetic and environmental factors such as selenium deficiency, iodine excess, stress, and infections. Gut microbiome disorders may be one of these factors. There is growing evidence that the gut microbiome interacts with the human immune system and may contribute to the development of autoimmune diseases.

5. Nutrients, Minerals, and Natural Ingredients

The following section separates traditional use from scientific evidence, as required. Sources are exclusively peer-reviewed publications accessed via NIH/PMC or identified in PubMed-indexed literature.

5.1 Selenium

Traditional and background context: Selenium is an essential trace element whose dietary sources include Brazil nuts, seafood, organ meats, and cereals. Its relationship to thyroid physiology derives from its role as a cofactor in selenoproteins, including iodothyronine deiodinases and glutathione peroxidases, making it integral to thyroid hormone metabolism and antioxidant defense. This biochemical relationship, rather than a discrete traditional herbal use, underlies its study in thyroid conditions.

Scientific evidence:

Selenium is an essential trace element required for thyroid hormone synthesis and exerts antioxidant effects, making it potentially relevant in the management of Hashimoto's thyroiditis.

A 2024 systematic review and meta-analysis of randomized controlled trials (RCTs) — evaluating selenium's effect on thyroid function (TSH, fT4, T4, fT3, T3), thyroid antibodies (TPOAb, TGAb, TRAb), ultrasound findings, immune markers, and patient-reported outcomes in Hashimoto's thyroiditis — analyzed a total of 687 articles, of which 35 were identified and analyzed. Participants were severely selenium-deficient in 9 of the 18 studies that checked baseline selenium levels (50%), mildly deficient in 7 studies (39%), and selenium-sufficient in only 2 studies (11%). This is a key limitation: the majority of positive findings come from populations with pre-existing selenium deficiency.

A separate systematic review and meta-analysis published in PMC (2023) that included 21 RCTs with a total of 1,610 subjects found that serum TPOAb was significantly reduced after selenium supplementation at 3 months (SMD = −0.46, 95% CI: −0.74 to −0.18, P = .001) and 6 months (SMD = −0.80, 95% CI: −1.38 to −0.21, P = .008), and that serum TgAb levels decreased at 3 months but not at 6 months.

However, an earlier systematic review (7 controlled trials, 342 patients) found that there was no significant change in TPOAb levels (WMD = −124.28 [95% CI: −631.08 to 382.52], P = .631) after 3 months of treatment. The efficacy of selenium supplementation in HT patients remains controversial; the majority of studies have focused on serum TPOAb and TgAb autoantibody levels.

The Cochrane systematic review on this topic concluded that evidence to support or refute the efficacy of selenium supplementation in people with Hashimoto's thyroiditis is incomplete and not reliable to help inform clinical decision making. Overall, evidence strength for selenium is moderate and mixed: reductions in autoantibody levels have been demonstrated in some trials, but clinical relevance to patient outcomes and thyroid function remains uncertain, and benefit appears most likely in selenium-deficient populations. Adequate selenium intake is considered vital in areas of iodine deficiency or excess, and in regions of low selenium intake a supplement of 50–100 μg/day may be appropriate.

5.2 Iodine

Traditional and background context: Iodine is an essential micronutrient historically recognized as critical for thyroid hormone synthesis; iodine deficiency has been the leading global cause of goiter and hypothyroidism for centuries. Public health iodization programs (salt iodization) emerged in the 20th century to address population-level deficiency.

Scientific evidence: The relationship between iodine and autoimmune thyroid disease is bidirectional and complex. The incidence of Hashimoto thyroiditis tends to be higher in countries with lower iodine deficiency prevalence — suggesting that excess iodine in previously deficient populations may be a trigger. Excessive iodine intake triggers oxidative stress and lymphocytic infiltration of the thyroid and has been implicated in autoimmune thyroid diseases. Iodine overcorrection is known to increase reactive oxygen species (ROS) in the thyroid gland.

Evidence in this area is predominantly observational and mechanistic. Both deficiency and excess have demonstrated adverse thyroid effects; current scientific guidance supports maintaining adequate but not excessive iodine intake in the context of Hashimoto's. Evidence strength: well-established for necessity; preliminary and epidemiological for the risk of excess in susceptible individuals.

5.3 Vitamin D

Traditional and background context: Vitamin D has a long history as a fat-soluble nutrient obtained from sunlight exposure and dietary sources. Its role in bone metabolism has been recognized since the early 20th century, while its immunomodulatory properties have become a major research focus over the past two decades.

Scientific evidence: Vitamin D is an essential nutrient that plays a crucial role in numerous biological functions, acting as a hormone and being important for the proper functioning of the immune system. Evidence in the literature illustrates interactions between adequate vitamin D levels and an appropriate immune response, with implications for Hashimoto's thyroiditis.

A comprehensive review of existing literature shows that vitamin D inhibits the secretion of pro-inflammatory cytokines, leading to an improvement in the clinical picture of HT by switching from a pro-inflammatory to immune balance. Vitamin D supplementation has been shown in some studies to reduce elevated serum levels of thyroid peroxidase antibodies, a key marker of HT.

In one study, vitamin D was deficient in 76.7% of HT patients and 70% of Graves' disease patients compared to 20.0% in healthy people. However, its role in preventive and therapeutic aspects was not proven. Lower vitamin D status has been found in HT patients than in controls, and inverse relationships of serum vitamin D with TPO/Tg antibodies have been reported. However, other data and the lack of trial evidence suggest that low vitamin D status is more likely the result of autoimmune disease processes that include vitamin D receptor dysfunction.

Although results are conflicting, the evidence suggests that adequate vitamin D intake supports immune function and may counteract autoimmune conditions such as HT by improving symptoms. Evidence strength: preliminary to moderate; association between deficiency and HT is consistent, but causality and therapeutic benefit are not definitively established.

5.4 Zinc

Traditional and background context: Zinc is an essential trace mineral with broad roles in immune function, enzyme activity, and protein synthesis. Its role in thyroid physiology relates primarily to its function as a cofactor in enzymes involved in thyroid hormone metabolism and antioxidant defense.

Scientific evidence: Magnesium and zinc are involved in thyroid hormone synthesis, antioxidant defense, and immune regulation. Anti-inflammatory nutrients including zinc are considered important to reduce thyroid inflammation. Treatment of anemic women with impaired thyroid function with iron improves thyroid-hormone concentrations, while thyroxine and iron together are more effective in improving iron status. Evidence for zinc specifically in Hashimoto's is limited to observational associations and mechanistic reasoning; robust clinical trials are lacking. Evidence strength: preliminary; predominantly mechanistic.

5.5 Iron

Traditional and background context: Iron is required for thyroid peroxidase (TPO) activity, the enzyme responsible for iodine organification in thyroid hormone synthesis. Iron deficiency anemia has long been associated with impaired thyroid function in clinical nutrition literature.

Scientific evidence: Treatment of anemic women with impaired thyroid function with iron improves thyroid-hormone concentrations. Clinicians are advised to check patients' iron status, particularly in menstruating women, to correct any deficiency. Evidence strength: moderate for iron deficiency correction in thyroid-impaired, iron-deficient women; more limited for iron supplementation in iron-replete HT patients.

5.6 Polyunsaturated Fatty Acids (PUFAs) and Omega-3 Fatty Acids

Traditional and background context: Omega-3 fatty acids from marine sources (EPA, DHA) and plant sources (alpha-linolenic acid, ALA) have been used in traditional diets in coastal and northern populations for centuries. Their anti-inflammatory properties have been a focus of modern nutritional research across multiple inflammatory and autoimmune conditions.

Scientific evidence: Higher total polyunsaturated fatty acids (PUFAs) and α-linolenic acid (ALA) intake were significantly associated with lower HT risk, and subgroup analysis revealed that α-linolenic acid intake was significantly lower in females than in males, potentially contributing to their greater susceptibility to HT. In a validation study, higher erythrocyte membrane levels of total n-3 PUFAs, ALA, and eicosapentaenoic acid (EPA) were significantly associated with a low prevalence of HT. Evidence strength: preliminary; based primarily on cross-sectional and observational data. Intervention trials in HT specifically are limited.

5.7 Myo-Inositol

Traditional and background context: Myo-inositol is a naturally occurring carbocyclic sugar found in fruits, beans, grains, and nuts. It does not have a long history of use as a traditional herbal remedy per se, but it has been used in nutritional medicine particularly in the context of polycystic ovary syndrome (PCOS) and metabolic conditions. Its study in thyroid conditions emerged from its biochemical role in intracellular signaling pathways.

Scientific evidence: Myo-inositol (MYO) is the most abundant stereoisomer of the inositol family and has a relevant role in thyroid function and autoimmune diseases as a precursor of phosphoinositides that participate in the phosphatidylinositol signal transduction pathway. Among phosphoinositides, phosphatidylinositol 4,5-bisphosphate (PIP2) is the precursor of inositol triphosphates (IP3), second messenger of several hormones including TSH. As a second messenger, myo-inositol is essential to produce H₂O₂ required for the synthesis of thyroid hormones.

Multiple clinical studies have shown that after treatment with myo-inositol plus selenium (MYO+Se), TSH levels significantly decreased in patients with subclinical hypothyroidism with or without autoimmune thyroiditis. The TSH reduction was accompanied by a decline of antithyroid autoantibodies.

A randomized trial of 168 HT patients with subclinical hypothyroidism found that patients receiving myo-inositol plus selenium (MI-Se) saw TSH, anti-TPO antibody, and anti-thyroglobulin antibody levels significantly decreased; a significant free serum T4 increase was also observed in the MI-Se group, along with an amelioration of patients' quality of life. The authors noted that additional research is necessary in larger populations to evaluate the effect on quality of life and to study the mechanism of the effect on chemokines. Evidence strength: preliminary to moderate; promising results from small RCTs, but most evidence involves the combination of myo-inositol with selenium rather than myo-inositol alone.

5.8 Ashwagandha (Withania somnifera)

Traditional use: Ashwagandha (Withania somnifera (L.) Dunal) is a traditional medicine in Ayurveda, and is often prescribed in that tradition for thyroid dysfunctions. In Ayurvedic medicine, it is classified as a rasayana (rejuvenator) and adaptogen, used historically for fatigue, debility, and endocrine support.

Scientific evidence: One pilot study was designed to evaluate the efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients, given that subclinical hypothyroidism occurs in 3–8% of the global population. A prospective, randomized, double-blind, placebo-controlled study enrolled 50 subjects with elevated serum TSH levels (4.5–10 μIU/L), aged between 18 and 50, randomized to either treatment or placebo groups for an 8-week treatment period. 600 mg/day of ashwagandha root extract administered for eight weeks resulted in significant increases in serum T3 and T4 levels, along with a corresponding reduction in TSH.

This study is a small pilot trial. It is important to note that many findings in this area have come from animal models; therefore, while promising, they should be interpreted with caution. Evidence strength: very preliminary; one small single-center RCT in subclinical hypothyroidism (not specifically Hashimoto's). Animal and mechanistic data provide supporting context. Larger trials are needed.

5.9 Nigella sativa (Black Seed / Black Cumin)

Traditional use: Nigella sativa, a potent herbal medicine, has seen continuing and increasing worldwide use as an alternative treatment for several chronic diseases including hyperlipidemia, hypertension, and type 2 diabetes mellitus. It has been used in traditional Islamic medicine, Unani, and Middle Eastern folk medicine for centuries for a wide variety of conditions, including inflammatory and metabolic disorders.

Scientific evidence: Forty patients with Hashimoto's thyroiditis, aged between 22 and 50 years old, participated in a trial and were randomly allocated into two groups receiving powdered Nigella sativa or placebo daily for 8 weeks. Treatment with Nigella sativa significantly reduced body weight and body mass index (BMI). Numerous studies have extensively studied therapeutic actions of Nigella sativa in improving chronic disease status, particularly in animal models; human studies in this field are scarce and limiting. Moreover, the health effects of Nigella sativa in Hashimoto's thyroiditis had been studied in only one animal model prior to this human trial. Evidence strength: very preliminary; one small RCT in HT, primarily with anthropometric outcomes. Human evidence specifically for thyroid autoimmunity is limited.

6. Dietary Patterns and Lifestyle Factors

6.1 Mediterranean Diet

The Mediterranean diet (MedD) exerts anti-inflammatory and antioxidant effects that are considered beneficial in autoimmune thyroid diseases. The main characteristics of the Mediterranean diet include high intake of food from vegetable sources (vegetables, legumes, fresh fruits, nuts, whole grains), and olive oil as the principal source of fat; moderate consumption of red wine with meals; low to moderate intake of animal-based products, mainly represented by fish, dairy products, poultry, and eggs, with a limited quantity of red meat and processed meat products.

Thanks to its high content in natural antioxidants, fibers, and micronutrients, the Mediterranean diet positively influences immune system function, gut microbiota composition, and redox balance, exerting antioxidant, anti-inflammatory, and immunomodulatory effects. HT patients adhering to an anti-inflammatory diet exhibited lower TSH levels, higher free T4 levels, and lower BMI values. Higher adherence to the Mediterranean diet also improved thyroid autoimmunity and related dysfunction.

In general, an individually selected diet, especially the Mediterranean one, which is anti-inflammatory, can support thyroid function and reduce the risk of developing metabolic and mental disorders.

6.2 Gluten-Free Diet

The gluten-free diet (GFD) is among the most discussed dietary interventions for HT, driven largely by the association between Hashimoto's and celiac disease.

HT may be associated with nonthyroidal autoimmune diseases, including celiac disease or other gluten-related conditions. In recent years, interest in the gluten-free diet has increased for its supposed extra-intestinal anti-inflammatory effect; thus, many patients with HT initiate the GFD on their own.

A 2025 systematic review and meta-analysis of GFD in non-celiac HT patients found that the pooled data revealed the evidence was very uncertain about the effect of GFD compared to control groups on TSH, fT3, fT4, and anti-TPO, with only anti-Tg showing a marginally significant reduction (MD -10.07 IU/mL; p = 0.010).

A clinical study in which 31 women with AIT followed a gluten-free diet for 8 weeks found that the only significant difference in blood parameters was the TPOAb level in the placebo group between weeks 4 and 8, and the microbiome changes observed — including significant increases in Desulfobacterota, Proteobacteria, Prevotella, and Parasutterella and decreases in Actinobacteriota, Coriobacteriaceae, and Bifidobacterium — may indicate increasing inflammation. For now, a gluten-free diet should be used cautiously in AIT.

Current data support lifelong GFD in celiac disease and suggest that patients with both celiac disease and HT may gain indirect thyroid-related benefit as intestinal inflammation improves. By contrast, evidence remains insufficient to recommend routine gluten withdrawal for all patients with non-celiac HT.

6.3 Anti-Inflammatory Dietary Approaches

Diet can be a complementary treatment for Hashimoto's disease by affecting thyroid function and anti-inflammatory properties, though it is still unclear which dietary strategy would be the most beneficial. Anti-inflammatory nutrients such as vitamin D, antioxidants, monounsaturated and polyunsaturated fatty acids, magnesium, and zinc are considered important to reduce thyroid inflammation.

6.4 Gut Microbiome and Dietary Fiber

The gut microbiome may contribute to the development of autoimmune diseases such as autoimmune thyroiditis. Diet has a critical impact on the gut microbiome. There is growing evidence of the existence of a thyroid–gut axis that controls many autoimmune disorders, and patients frequently report changes in their quality of life and thyroid function as a result of dietary modifications. Evidence for specific probiotic or prebiotic interventions targeting HT remains limited.

6.5 Physical Activity

Lifestyle modifications including eating healthy food and exercising regularly can help manage the symptoms and improve the quality of life in hypothyroidism. Despite the great significance of environmental factors, including behavioral ones, both in the etiology and prevention and treatment of hypothyroidism, the limited scale of pro-health behaviors in the lifestyle of patients has been confirmed in numerous studies. Formal clinical trials examining specific exercise protocols in HT populations remain limited.

6.6 Stress and Sleep

Stress is among the environmental factors identified in the literature as influencing the risk of developing autoimmune thyroiditis. Chronic stress is recognized as one of the environmental factors that plays an important role in the pathogenesis and clinical course of HT. Mechanistic links between the hypothalamic–pituitary–thyroid (HPT) axis and the hypothalamic–pituitary–adrenal (HPA) stress-response axis are well documented in animal and observational human research, though interventional trials on stress management in HT specifically are sparse.

7. Summary of Evidence Strength

• Selenium: Mixed; meta-analyses show antibody reductions in some trials, particularly in selenium-deficient populations, but Cochrane review found insufficient evidence for clinical decision-making.
• Iodine adequacy: Well-established as essential; both deficiency and excess are implicated in thyroid dysfunction; optimal intake range is supported by epidemiological and mechanistic evidence.
• Vitamin D: Consistent observational association between deficiency and HT; supplementation evidence is preliminary and conflicting; causality not established.
• Zinc and Iron: Mechanistically plausible; correction of deficiency supported, particularly for iron in menstruating women; specific HT intervention trial data are limited.
• Omega-3/PUFA: Observational and cross-sectional evidence supports association with lower HT risk; intervention trial data in HT are insufficient.
• Myo-inositol (+selenium): Promising small RCT data for reduction in TSH and antibodies in subclinical hypothyroidism/HT; larger trials needed.
• Ashwagandha: One small RCT in subclinical hypothyroidism showed improvement in thyroid hormone levels; evidence is very preliminary; Hashimoto's specifically unstudied.
• Nigella sativa: One small RCT in HT; very preliminary with limited thyroid-specific outcomes.
• Mediterranean diet: Observational and pilot trial data suggest benefit in HT; consistent with established anti-inflammatory nutrition principles.
• Gluten-free diet (non-celiac HT): Insufficient evidence to recommend broadly; may carry microbiome risks; supported in concurrent celiac disease.

References

• Mincer DL, Jialal I. Hashimoto Thyroiditis. StatPearls. NCBI Bookshelf (NIH), 2026.
• Ingbar SH. Hashimoto's Thyroiditis. Endotext. NCBI Bookshelf (NIH).
• Frontiers in Endocrinology: Hashimoto's thyroiditis: from pathogenesis to clinical management. PMC, 2026.
• Mincer DL, Jialal I. Hashimoto Thyroiditis. PubMed, 2017.
• Hypothyroidism. The Lancet, 2024.
• Taylor PN et al. Global epidemiology of hypothyroidism. PubMed (Nat Rev Endocrinol), 2017.
• Chaker L et al. Epidemiology, Types, Causes, Clinical Presentation, Diagnosis, and Treatment of Hypothyroidism. PMC, 2023.
• Hypothyroidism in Clinical Practice. Mayo Clinic Proceedings, 2018.
• Huwiler VV et al. Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. PMC (Thyroid), 2024.
• Clinical efficacy of selenium supplementation in patients with Hashimoto thyroiditis: A systematic review and meta-analysis. PMC, 2023.
• van Zuuren EJ et al. Selenium Supplementation for Hashimoto's Thyroiditis: Summary of a Cochrane Systematic Review. PubMed (Eur Thyroid J), 2014.
• Rayman MP. Multiple Nutritional Factors and the Risk of Hashimoto's Thyroiditis. PubMed, 2017.
• Minerals: An Untapped Remedy for Autoimmune Thyroiditis (Hashimoto's Thyroiditis). PMC, 2020.
• The Impact of Vitamin D on Immune Function and Its Role in Hashimoto's Thyroiditis: A Narrative Review. PMC, 2024.
• The Influence of Nutritional Intervention in the Treatment of Hashimoto's Thyroiditis—A Systematic Review. PMC, 2023.
• Investigating the associations between dietary nutrient intake and risk of Hashimoto's thyroiditis. PMC, 2025.
• Nutrition and Micronutrient Interactions in Autoimmune Thyroid Disorders: Implications for Cardiovascular Health. PMC, 2025.
• Rodziewicz A et al. Gluten-Free Diet Alters the Gut Microbiome in Women with Autoimmune Thyroiditis. PMC (Nutrients), 2024.
• Beyond celiac disease: the potential role of gluten in Hashimoto's thyroiditis. Frontiers in Endocrinology, 2026.
• Effects of Gluten-Free Diet in Non-Celiac Hashimoto's Thyroiditis: A Systematic Review and Meta-Analysis. PubMed, 2025.
• The Role of Inositol in Thyroid Physiology and in Subclinical Hypothyroidism Management. PMC, 2021.
• Myo-inositol in autoimmune thyroiditis, and hypothyroidism. PubMed, 2019.
• Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto's patients with subclinical hypothyroidism. PubMed, 2017.
• Unlocking the Therapeutic Potential: Selenium and Myo-Inositol Supplementation in Thyroid Disorders. PMC, 2025.
• Farhangi MA et al. Effects of Nigella sativa on thyroid function in Hashimoto's thyroiditis: a randomized controlled trial. PMC (BMC Complement Altern Med), 2016.
• Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients. J Altern Complement Med, 2018.
• The Role of the Immune System in the Course of Hashimoto's Thyroiditis: The Current State of Knowledge. PMC, 2024.
• The Impact of Environmental Factors on the Development of Autoimmune Thyroiditis—Review. MDPI Biomedicines, 2024.
• Clinical Relevance of Environmental Factors in the Pathogenesis of Autoimmune Thyroid Disease. PMC (Endocrinol Metab), 2016.
• Hashimoto's disease. MedlinePlus Genetics (NIH).
• Effects of Dietary Habits on Markers of Oxidative Stress in Subjects with Hashimoto's Thyroiditis: Comparison Between the Mediterranean Diet and a Gluten-Free Diet. PMC, 2025.
• Physical Activity, Nutritional Behaviours and Depressive Symptoms in Women with Hashimoto's Disease. PMC, 2025.